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ABSTRACT 
Cataracts are a common cause of visiOn loss in the elderly. 
Once non-surgical methods of treatment are reliably tested, eye 
drops, injections, tablets, or diet changes may prevent, delay, or 
reverse some forms of cataracts. The treatment depends on whether 
the cause is from chemicals, radiation, age, or diabetes. Treatments 
include nutritional supplements, organic compounds, plant and 
extracts, aldose reductase inhibitors, and others. Some cataracts 
may be preventable. 
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NON-SURGICAL TREATMENT OF CATARACTS 
IN1RODUCTION 
Since ancient times scientists and people strammg to see 
through cataracts have been searching for a safe treatment to 
prevent, stabilize, or clear cataracts without resorting to surgery. 
Cataract surgery is one of the safest and becoming more safe. 
Complications such as cystoid macular edema, retinal detachment, 
and hemorrhage occur with less frequency as surgical techniques 
improve. Unfortunately surgery is expensive. With the aging of the 
population, more people will be looking toward Medicare to pay for 
their cataract surgeries, putting an increasing burden on taxpayers. 
Medicare requires 20/50 or worse visual aquity before approving 
cataract surgery; so, many people will have to wait longer and may 
be willing to try cataract medicines during that time. 
Reports of success of different drugs, vitamins, and extracts 
vary along with the methods of measurements which are not always 
well-accepted. The success also depends on the cause and stage of 
the cataract. The FDA currently allows only one prescription drug for 
cataracts in the United States while other countries abound with 
many. Even more are being tested all over the world. The best 
treatment for cataracts may be to prevent them with healthy living 
and eye protection. 
HISTORY 
The search for a non-surgical treatment for cataracts was 
underway as far back as Hippocrate's time (about 400 B.C.). Besides 
dietetics and physical medicine, direct and indirect treatments 
included water, wine, vinegar, honey, milk, bile, urine, feces and 
blood from different animals. The Egyptians used feces, also, called 
"Dreckapotheke." Galen (about 150 A.D.) used hyena or crocadile 
livers, pigeon blood, Aconitum, Hyoscyamus, and Aloe. Feces 
treatment appears again in Petrus Hispanus' (Pope John XXI) book, 
Thesarus Pauperum, from the 13th century. George Bartisch of the 
16th centruy used Althea and Aconitum against the "blue cataract."! 
In the last century medicinal treatments for cataracts have 
undertaken two general aims--to absorb the opacities by local 
application to the eye and to improve nutrition or metabolism of the 
body. Of the drugs used to absorb opacities, iodine was one of the 
most common. It was administered in the form of drops, washes, 
salves, injections, iontophoreses, and by mouth. Other elements were 
sometimes used with iodine including calcium and potassium. 2 
(Calcium, which increases with age and in cataracts, is important m 
maintaining lens membrane permeability. Potassium diminishes m 
the cataractous lens.) 
Other drug treatments were attempted with various theories 
for effectiveness. Dionine, boracic and glycerine, and injections of 
cyanide of mercury or lactogenin (a milk preparation) were 
administered to produce local hyperemia for "better nutrition." 
Romer (1907) claimed that a body's faulty metabolism caused lens 
toxins which could be immunized against. Some tried lentocalin, 
caractolysin (an emulsion of cataractous lenses, 1926), and beef or 
fish lens extracts with no results.2 Rabinovich recommends 
improving metabolism of the lens by blowing a thin stream of 
oxygen over the eye or by administering subconjunctival injections. 
He adds that this treatment would need to be permanent to maintain 
good results.3 Some attempted to supply the lens with deficient 
factors including sulphydril compounds (glucothiose) and abundant 
vitamins. Cysteine, infinitesimal doses of naphthalene (which can 
cause cataracts), secale, tincture of cineraria maritima, syrup of 
hydriodic acid, iodonucleiod, dilute sodium thiocyanate (a poison), 
and many more concoctions have produced varied reports.2,4 
Some scientists tried physical methods to prevent or retard 
cataracts. These methods include radium (even though it causes 
cataracts), pneumo-massage and electrotherapy. Schon (1887) 
recommended glasses to decrease the strain on the ciliary muscle.2 
Another methodology was to treat disorders of the body first. 
Rabinovich treated central nervous system problems (using 
anesthetics like novocain), allergies, and atherosclerosis. Some 
thought senile cataracts were caused from endocrine failure; and so 
they tried parathyroid, thyroid, and ovarian extracts. For adreno-
pituitary problems, Rabinovich gave cortisone (which can cause 
cataracts), aspirin, and other drugs.3 Early control of diabetes has 
been shown to reverse cataracts. Duke-Elder believes all aspects of 
health should be considered including diet, habits, and stress.2 Many 
of these "therapies" are being tested and used currently. 
LENS ANATOMY, COMPOSITION, AND :METABOLISM 
The lens is suspended behind the iris and bathed by the 
aqueous humor. The aqueous humor provides oxygen and nutrients 
since the lens has no blood supply. The lens grows when the 
epithelial cells in the anterior lens reproduce and elongate at the 
equator creating spindle-shaped fibers reaching from pole to pole. 
As the fibers pack down toward the center, or nucleus, they lose 
their organelles making them more transparent. The fibers 
surrounding the densely-packed nucleus make up the cortex. A 
tough, elastic capsule surrounds the lens and restricts penetration of 
various molecules based on size, charge, and lipoid solubility. 
The lens is composed mostly of water and protein. The 66% of 
the human lens which is water allows for flexibility and 
transparency. Dehydration is maintained by Na+ ion-water pumps 
within the cell membrane. Protein comprises 33% of the lens which 
is higher than other tissues in the body. Protein gives the lens a 
higher index of refraction as well as support. The water-soluble 
crystallins comprise 85% of the protein and minimize scatter. The 
insoluble (albuminoid) proteins which make up about 15% attach to 
or are part of the lens fiber membranes. 
The remaining elements comprise less than 2% of the lens. 
These include K+, Na, Ca, Mg, Phosphate, Cl, bicarbonate, and some 
trace elements. Active ion pumps extrude Na+ and take in K+. 
Amino acids and inositol are also actively transported in. The lens 
has a higher concentration than the aqueous of K+ (25x), amino acids 
(2-6x), and inositol (95x). Certain components have a higher 
concentration in the lens than other tissue in the body: Glutathione, 
ascorbic acid, inositol, and taurine. 
Glutathione, an important polypeptide, is mostly in the reduced 
form (GSH). About 7% is oxidized as GSSG. GSH prevents alterations 
in protein linkages, maintains solubility and transparency by 
maintaining high levels of reduced sulfhydryl (SH-) groups. GSH also 
maintains transport pumps and molecular integrity of fiber 
membranes. Glutathione peroxidase is an enzyme which removes 
H202 or toxic lipid peroxides. 
Lipids--cholesterol (50%), phospholipids ( 45% ), and 
glycosphingolipids and ceramides (5%)--comprise 3-5% of the dry 
weight of the lens. They are a major component of the lens fiber 
membrane. 
Respiration is chiefly by anaerobic glycolysis (80%) except in 
the epithelium where it is aerobic (5%). The pentose shunt uses 15% 
of the glucose. The energy is used for protein and GSH synthesis, ion 
and water pumps, and carbohydrate, electrolyte, and amino acid 
transport into the lens. NADPH, generated by the pentose shunt, 
maintains GSH.S 
CATARACT BIOCHEMISTRY 
The list of causes of cataracts is very extensive and includes 
trauma, chemicals, radiation, electricity, viruses, vitamin or amino 
acid deficiencies, repeated dehydration, diseases, chromosomal 
abnormalities, and ocular disease. The following sections explain 
some of the basic biochemistry of senile, experimental, diabetic, 
galactosemic, radiation, and traumatic cataracts. 
Senile Cataracts 
In the U.S., 50% of people 75 or older have cataracts causing 
20/30 or worse vision. This normal change in the lens develops as 
the nucleus becomes more dense and less transparent ("nuclear 
sclerosis") due to crosslinking of proteins. It may be paralleled by a 
yellow or brown discoloration. Small opacities or vacuoles may be 
seen along the lens sutures or fibers. Vacuoles result from fluid 
between the fibers from increased N a+ or other active compounds. 
The increase in fluid breaks the membranes. Some senile cataracts 
begin as posterior cortical or subcapsular cataracts. If the 
"immature" cataract develops into a "mature" cataract, the lens 
becomes white. 
One of the earliest events in the formation of cortical cataracts 
is a reduction of GSH which also occurs with age. This is associated 
with fiber membrane destruction and protein S-S bond formation. 
Enzymes associated with glutathione also decrease activity with age. 
Other protein changes occur with age causing less transparency. The 
percent of insoluble proteins increases. In bovine lenses, more of the 
soluble, high molecular weight a-crystallins aggragate creating giant 
macromolecules capable of causing opacities when in high enough 
concentrations. 
A decrease in synthesis or impaired degradation of lipids 
causes membrane damage leading to cataracts. Ceramides, 
precursers to sphingomyelin (one of the four types of lipids found m 
the lens) increases in senile cataracts while sphingomyelinase 
decreases.S 
Experimental cataracts 
Experimenters induce cortical cataracts with x-rays, diabetes, 
and various chemicals such as ouabain, chlorpromazine, triparanol, 
H202, aminotriazol, and arachidonic acid. Most of these 
cataractogenic agents lead to the loss of GSH causing an increase in 
NADPH, loss of K+, inositol, and amino acids; gain in Na+ and Ca++, a 
decrease in protein synthesis, a higher percentage of insoluble 
protein, an increase in protein S-S, a decrease in most enzyme 
activity except for an increase in hydrolytic enzymes, and a decrease 
in A TP content.5 
Diabetic cataracts 
Cataracts can occur in adults with uncontrolled diabetes 
mellitus. The development of cataracts correlates to the duration of 
diabetes in years. They usually occur between age 3 and 33.6 They 
appear bilaterally as small snowflakes or cortical opacities and begin 
at the lens equator. In later stages, subcapsular opacities make way 
for increased numbers of vacuoles and waterclefts.6 These types of 
cataracts are also found in people with hypoparathyroidism and 
myotonic dystrophy. Increased glucose in the lens and aqueous 
parallels that of the changing amounts in plasma. Glucose levels are 
lower in the aqueous than in the blood. The lens contains about 60 
mg% which is about half of the blood leve1.6 Glucose in excess of 200 
mg/100 ml saturates the regulating enzyme, hexokinase. Then the 
extra glucose causes abnormal protein glycosylation and auto-
oxidation to sorbitol. Although human lenses accumulate only small 
amounts of sorbitol, excess sorbitol causes an increase in hydration 
along with an increase in Na+ and a decrease in K+, inositol, and 
amino acids.5 
Galactosemic cataracts 
Galactosemia is a relatively rare congenital disease due to 
enzyme absence or deficiency leading to excess serum galactose 
when milk is ingested. Cataracts occur in 75% of persons with this 
disease.6 Excess galactosemia leads to formation and accumulation of 
galactitol which can cause cataracts from hydration. Early cataracts 
appear like a "drop of oil." Other forms are zonular, nuclear, anterior 
cortical (striations), and dust-like.6 If treated before the third 
month they may regress. Aldose reductase inhibitors can prevent 
them. 
Radiation cataracts 
Radiation cataracts begin in the equator and posterior 
subcapsular areas and progress into the cortex. They are due to 
several mechanisms. Radiation affects the membrane permeability 
and allows K+, inositol, and glutathione leak out. It causes a decrease 
in soluble proteins and the number of amino acids in proteins. The 
epithelium becomes damaged and mitosis is arrested. Younger 
lenses are more susceptible. In humans, cataracts can result from 
300 or more roentgens. In experiments, animal lens can be 
protected with prior thiourea, glutathione, or cysteine. 
Traumatic cataracts 
Mechanical or chemical damage to the lens fibers can cause 
increased outward leakage of K+, inositol, and amino acids. 
Depending upon the magnitude of an injury, a cataract may progress 
or "repair" with new lens fiber growth and appear as a zonular 
cataract. An ocular contusion may cause a rosette-shaped cataract 
which may regress or develop into a total cataract.6 Mechanical 
trauma stimulates more thymidine to be incorporated in the DNA. 
The resulting "repair" cells thicken under the lens capsule in many 
cataracts. 
CATARACT TREATMENTS 
Nutrition 
Nutrition affects the eye as well as the rest of the body. 
Controversy and concern exist over whether nutritional aids reduce 
cataract formation and that some people may take toxic levels. 
Although low nutrition hasn't experimentally caused human 
cataracts, it may determine their rate of formation. 7 Gary Price 
Todd, M.D., promotes nutritional therapy. He claims 50% of cataract 
patients could have restored enough vision with proper nutritional 
supplements to delay surgery .8 With a hair analysis he first 
determines toxic and deficient levels of different minerals and 
metals. The nutritional recommendations of others such as Alex 
Duarte, O.D., parallel Todd's.9 Deficiencies in folic acid, niacin, vitamin 
B 12, and vitamin E have caused congenital ocular defects including 
cataracts. Deficiency of tryptophan, an amino acid, also causes 
cataract.l 0 A case-control study in India found reduced cataracts 
with increased consumption of foods rich in protein and other 
nutrients.11 Many eyedrops for cataracts have been formulated 
with vitamins and minerals as well as diets with oral vitamins and 
mineral. 
The main vitamins used to treat cataracts are vitamins C, 
B 1 ,2,3,5, and 6, and E. High levels of vitamin C are found in the 
human lens (9 mg%) and aqueous (17 mg%) compared to the blood 
(1.2 mg%).6 Concentrations of ascorbate in the lens decrease with 
the onset of cataracts and are found only in trace amounts in opaque 
lenses.6 
Vitamin C acts as a free scavenger and antioxidant blocking 
free radicals' destructiveness alone or coupled to glutathione, and 
retards UV -induced crystallin aggregation. It also regenerates the 
oxidized form of vitamin E. When added to incubation medium, it 
can inhibit darkening of human lenses exposed to long-wave UV 
light.12 Dr. Todd claims that brunescence from intense light is 
reversible with vitamin C, although it takes many months.8 Rats fed 
higher amounts of vitamin C had delayed high molecular weight 
protein aggregate formation in their lenses after UV exposure. This 
is an indication of the protection vitamin C gives to the structural 
proteins in the lens .13 Though deficiency of ascorbate has caused 
cataracts only in guinea pigs,14 persons with higher amounts of 
ascorbate/L of plasma had less chance of developing advanced 
subcapsular cataract in one study .15 In other studies, subjects with 
high plasma levels of two of the three vitamins E, C, or carotonoids (a 
provitamin) had reduced risk of cataracts compared to subjects with 
low levels of one or more.16,17 
Vitamine C Faure (Lab H. Faure, France) contains vitamin C in 
an eyedrop preparation.? Although the RDA for vitamin C is 30 mg 
for adults, Dr. Ortiz, an ophthalmologist, suggests 1500 mg for 
patients age 55 and 2000 mg for patients with cataracts.18 Dr. Todd 
and Dr. Duarte recommend 500-1000 mg for cataract patients since 
additional vitamin C would pass through an otherwise unstressed, 
healthy body.9,8 
The B vitamins are involved mainly as catalysts in energy 
production and protein metabolism. Riboflavin (B2) is needed to 
produce glutathione reductase, and enzyme important in lens 
protection from free radicals. Deficiency of riboflavin causes 
cataracts in many lab animals, but not humans.10 Congenital ocular 
defects including cataracts occur with deficiencies of niacin and 
vitamin B12.18 Dr. Todd claims that high doses of B-complex benefit 
some cataract patients.8 Dr. Ortiz recommends up to 100 mg of B2 in 
cataract patients.IO European companies have produced eyedrop 
preparations such as Opacinan which is made up of thiamine (Bl), 
riboflavin (B2), pantothenic acid (B3), nicotinamide (B5) and 
pyridoxal (B6). Eyedrop combinations of B vitamins with other 
components to increase lens energy levels include Catechol POS, 
Catarstat, Antikatarakticum and Phakoskerom. 7 
Vitamin E (tocopherol) protects lipids against free radicals. 
Some scientists reported vitamin E or mixtures protect against 
cataract in rats but results were obtained by scanning electron 
microscopy and have not been repeatable. 7,19 The rate of cataracts 
was reduced by 56% by taking 400 IU of vitamin E in an Australian 
study. Cataracts were reduced 70% with vitamin E and 300 mg of 
vitamin C.20 Dr. Todd found milky cortical cataracts cleared up 
while treating patients with vitamin E for other eye problems. 
Vitamin E deficiency will produce reversible cataracts in diabetic 
patients.8 The RDA for vitamin E is 30 IU (adults) and Todd 
recommends a minimum of 400 IU.8 Ortiz suggests 200-400 I.U. at 
age 55 and 400 I.U. for cataract patients.18 Alpha-tocopherol 
protects lipid membranes from free radical attack.? Seletec (R), a 
selenium-a-tocopherol mixture is injected and administered orally to 
treat cataracts in dogs.7 
Selenium, the other component of Seletec (R), is a trace 
element that works parallel to vitamin E as an antioxidant. It is part 
of the enzyme glutathione peroxidase. Ortiz suggests 200 meg if 
needed. Todd recommends 200-1000 meg for four to six 
months.21 ,8 Excess selenium may cause cataracts as well as 
deficient amounts.15 
Calcium, another important mineral, maintains lens membrane 
permeability. Calcium deficiency associated with 
hypoparathyroidism and tetany causes zonular cataracts.lO These 
may be preventable if treated early. Increased calcium deposits are 
found in cataracts and with age. Other countries have developed eye 
drop mixtures containing calcium (Colin-resol, lodocol, and 
Iodocalcium-POS). Other inorganic formulations contain lithium, 
magnesium, potassium, iodide and others in eye drops.? 
Some minerals also affect the lens. Zinc increases with age, but 
decreases in lenses with cataracts.12 Zinc enhances the eye's ability 
to use vitamin A.18 Zinc deficiency causes cataracts in trout.21 
Cataracts are found in some children with acrodermatitis 
enteropathica, a zinc-deficiency disease.21 Todd found reversals of 
cataract in several patients taking multivitamins containing zinc (22 
mg).21 
Excess copper from an intraocular foreign body, 
hypercupremia, or hepatolenticular degeneration results in a 
sunflower cataract.22 Lenticular copper decreases with age but 
increases with cataracts.12 
Organic compounds 
Other organic compounds including N,N Dimethylglycine (DMG), 
superoxide dismutase (SOD) and amino acids have roles in keeping 
the lens clear. N,N Dimethylglycine (DMG) is also known as pangamic 
acid or vitamin B 15. It is a metabolite composed of tertiary amino 
acids and found in food. In some studies it prevents posterior 
subcapsular cataract in susceptible animals.8,24 Oral SOD, and 
enzyme which scavenges superoxide radicals, is said to decrease 
presbyopia and early cataracts. Orgotein is an injection form of SOD 
combined with copper or zinc.7 
Thiol compounds--sulphur-containing amino acids such as 
glutathione, cysteine, cystaemine, cystamine, taurine, and AET (2-
amino ethyl isothiouronium bromide) protect against radiation 
cataracts. Taurine was found effective in two mice studies and 
improved visual acuity in a clinical trial. 7 The absence of 
tryptophan, another amino acid, causes cataracts in rats and guinea 
pigs.lO Glutathione, a polypeptide, is found as tablets and eye drops. 
It has been reported to delay experimental cataracts.7 Phakan, an 
amino acid preparation which is supposed to increase levels of 
reduced glutathione, can improve cortical cataracts slightly according 
to one study .23 
All of these vitamins, minerals, amino acids and other nutrients 
work together to keep our lenses clear by maintaining the right 
balance. Researchers and companies have tried to use this 
information with varying success to treat cataracts. Some drugs 
being tested use nutrients in combination with other substances. 
Energy promoting components 
Components such as inosine monophosphate, uridine 
monophosphate, adenosine monophosphate, adenosine trinucleotide 
phosphate, L-glutamic acid, succinate, aspartic acid, and others are 
found in various energy cycles such as Krebs. Though there is no 
evidence that topical instillation delays or improves cataracts, a few 
eye drop preparations include these components.7 
Nat ural products 
Extracts from plants and animals are used in several eye drop 
preparations. The plant extracts include digitoxin, digitalis (which 
alter aqueous flow), euphrasia, fennel, melissa, rose oils, and 
strychnine, and chlorophyll.7 Senecio cineraria and Hamamalis 
vulgaris plant extracts are used in succus cineraria maritima, 
currently the only available prescription for cataracts in the United 
States. The manufacturer claims 22.5% of 40 patients benefited and 
a reduction in experimental cataracts in rats measured 
spectrophotometrically and biomicroscopically. It acts as a 
lymphagogue, increasing circulation in ocular tissues.(Luyties 
Pharmacal Co., St. Louis)24 
Extracts are also taken from animals. Hormones and extracts 
from glands--testes, ovaries, thyroid, and parathyroid--have 
questionable relationships to the lens. Thyrotropin-releasing 
hormone instilled in dog's eyes improved their vision as assessed by 
their owners. An injection of a nonsteroidal gametic factor, partially 
from bulls' semen has been reported to improve cortical cataracts in 
dogs and humans significantly.7 
Extracts of parts of animal eyes, brains and placenta along with 
other ingredients are found in Conjunctisan A (R) drops. Cataracts 
were delayed in rats given Conjunctisan A compared to saline.24 
Clinical trials show improved visual acuities in 45% of patients and 
halted opacities in 36% of patients with senile cataract.25 
Aldose reductase inhibitors 
Aldose reductase inhibitors are used to prevent or delay sugar 
cataract. One of the compounds being studied is Sorbinil. 
Experimental diets high in galactose cause the galactose to diffuse 
into the lens and be converted via aldose reductase to dulcitol, a 
more complex sugar. Dulcitol can't leave through the lens membrane 
and causes water to flow into the lens, resulting in cloudiness from 
damage to the cells. The same process occurs with diabetic cataracts 
as glucose changes to sorbitol. Sorbinil, administered topically or 
systemically, inhibits aldose reductase. Rat studies have shown the 
Sorbinil will prevent and even reverse diabetic and galactose 
opacities and lens vacuoles if given within a specified time.26,27 
Some bioflavenoids (organic compounds usually associated with 
vitamin C) such as quercitin also slow the formation of sorbito1.28,29 
Other substances with varying degrees of inhibiting aldose 
reductase include chromones, anti-allergy drugs, nonsteroidal anti-
inflammatory agents, catalin, phacolysin, aspirin, and bendazac.7 
Miscellaneous 
Catalin, made of an analog of xanthommatin (a yellow pigment 
found in insect eyes), has been reported to delay naphthalene and 
irradiation cataracts in rabbits when injected or instilled. It has also 
delayed cataracts in clinical trials. It appears to work by suppressing 
the breakdown of tryptophan, a lens protein, and protecting lens 
capsule permeability. Intraperitoneal injections in rats decreased 
blood sugar levels, although it can decrease lenticular energy levels. 
It appears to be a weak aldose reductase inhibitor.? 
Aspirin is under study for some of its other effects as well as 
being a weak aldose reductase inhibitor. Epidemiologic reports of 
benefits of aspirin on cataracts vary. In a recent study, cataract 
extractions were less frequent in the group of people taking aspirin 
than the group taking a placebo, but the results were not statistically 
significant.30 Another study showed no protective effect.31 Some 
reports imply that high doses taken in rheumatoid arthritis and 
diabetic patients decrease the prevalence of cataract surgery. Others 
found decreased visual acuity with rheumatoid arthritis patients. 
Aspirin has a weak hypoglycemic effect which may affect diabetic 
cataracts. Its effect on the lens protein tryptophan is 
controversial.? ,9 It also binds to lens crystallins inhibiting cyanate 
or glucose from binding and preventing the brunescence which could 
result.32 
Phakolysin, made of sodium azapentacene polysulfonate, is 
claimed to prevent cataracts in vitamin C-deficient guinea pigs and 
delay congenital cataracts in the Nakano mouse. Clinical trials show 
slightly improved visual acuities.? 
Bendazac lysine which binds to lens crystallins improved 
acuities in double masked trials when taken orally. 7,32 It partially 
protected animal albumin and serum from heat- and UV ray-induced 
denaturation and delayed galactose cataracts in rats.7 It also 
protected against lens protein denaturation in vitro and in vivo in lab 
animals.33 
PREVENTION 
Determining risk factors may lead to better prevention. 
Different types of cataract were found to prevail more with lower 
educational achievement levels, nonprofessional occupations, current 
smoking, decreased residential cloud cover, occupational exposure to 
sunlight, increased blood pressure, decreased body mass index, use 
of cheaper cooking fuels, and decreased levels of an antioxidant 
index .11, 17 Some drugs are associated with cataracts. The use of 
aspirin less than once a month (other studies show no protective 
effect), gout medications, antipsychotic or other phenothiazine drugs, 
prior use of antidiabetic agents, systemic steroids, and 
benzodiazepines were found to elevate risk in some studies.31 A 
family history of cataracts and the use of eyeglasses by age 20 (a 
rough indication of myopia) also increased the risk of cataract.17 
Lower educational achievement may be related to socioeconomic 
class which would affect nutrition and stress. Caloric restriction may 
also delay senile cataract.13 
Protecting the eyes from ultraviolet (UV) light may prevent 
cataracts. In some experiments UV light causes cataracts. Ultra-
violet exposure inhibits Na+K+ATPase pump activity.32 It promotes 
cumulative damage from free radicals decreasing levels of GSH and 
other reducing agents.32 The absorption of UV and visible light 
generates yellow-brown pigments in the lens. Overexposure causes 
brunescent cataracts. Hats with brims that shade the eye and 
sunglasses with UV protection are safe precautions. Some contact 
lenses incorporate UV protection. U veline, an eye drop preparation 
made in Switzerland, claims protection against near UV light.7 
CATARACT MEASUREMENT 
Measuring the effects of anti-cataract agents usually begins 
with laboratory animals such as rats, chick embryos, rabbits, etc. 
The lenses of these animals can be examined by ophthalmoscopy or 
biomicroscopy. When removed they can be cross-sectioned and 
checked histologically for vacuoles and fiber cell disruption with a 
light microscope or examined with a scanning electron microscope. 
The degree of opacities in diabetic and galactose lenses can be 
correlated to radioassayed levels of sorbitol and dulcitol. Lenses can 
also be incubated in a medium containing the substance being tested. 
Then levels of the substance found inside the lens are measured to 
determine its penetration. 
Subjective measures of acuity done by observing animal 
behavior, such as how well they avoid running into objects, is not 
very well accepted. 
If determined safe and effective, clinical trials may proceed. 
double-masked clinical trials are best suited for these trials to take 
into account any placebo effect. 
The effects of cataract treatments are often judged clinically by 
visual acuity which tends to vary. Practice may improve acuities. 
Acuities don't necessarily measure only lens changes, but possibly 
macular function as well. Also, pupil size affects acuity, improving it 
with constriction in cortical cataracts and dilation in nuclear 
cataracts. If visual acuities are taken the Bailey Lovie chart should be 
used since it has equal logarithmic steps. Cataracts cause contrast 
sensitivity to decrease in the lower and mid-ranges even in the 
absence of acuity change. Another measure of acuity is resolution 
target projection ophthalmoscopy in which the examiner focuses an 
ophthalmoscope on the fundus and observes the smallest resolvable 
lines.34 Changes in the lens are sometimes measured by refractive 
index which may indicate swelling. Some studies use medical 
records of the frequency of cataract extractions.30,31 
Observations using slit-lamp microscopes can be drawn 
manually or recorded photographically. Examiners should be trained 
to evaluate cataracts by the area it covers, features, types/locations, 
density, and color by using standardized charts. Scheimpflug 
photography records the density of cataracts through different 
sections of the lens and is highly reliable and best for nuclear 
sclerosis. Another way to photograph the lens is with 
retroillumination which requires careful patient allignment and 
sometimes focusing at more than one layer to include all opacities.34 
Specular photography may help to see lens fibers on a smaller scale. 
CONCLUSION 
Searching for cataract treatment is not a recent undertaking. 
Many non-surgical methods are still being tested with varying 
success for the diverse types of cataract. More testing needs to be 
done with objective, double-masked clinical trials. The most hope for 
treatment lies with early cataract treatment, especially for diabetics, 
with nutrition and aldose reductase inhibitors. 
This is the age of the quick fix. Uncomplicated cataract surgery 
usually takes 30 to 40 minutes and only a few weeks of healing. 
Nutritional and preventative drug therapies may take months or 
years and only slow the development of cataracts. By slowing down 
the number of cataracts, however, the government will save many 
Medicare dollars. It may also delay the possible complications of 
surgery. Patients should be informed of all their options, especially 
if they are at a higher risk for surgical complications or have only 
one seeing eye. Optometrists and ophthalmologists should be aware 
of the appropriate cataract therapies as they become available and 
recommend them accordingly. 
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